Singapore Pte via Osome SG — Indian SaaS Founders
Singapore Pte is the ASEAN gold standard for Indian SaaS founders scaling into Asia-Pacific enterprise sales: IRAS CIT stability, IN-SG DTAA benefits (10% royalty withholding vs 20%), and regional brand credibility. Requires SG-resident director; Osome bundles nominee at SGD 1,080+/year.
Singapore applies IRAS CIT at 17% flat with startup exemption (75% on first SGD 100k for first 3 years).
India side: RBI Overseas Direct Investment (ODI) filing above USD 250,000 aggregate contribution; LRS caps outbound at USD 250k/year; Schedule FA on ITR-2 mandatory.
Model the full outlay, not just the setup fee
- SetupOsome (Singapore) setup$1,650
- AnnualYear 2 renewal$1,080
What the tax authority sees
Singapore Pte falls under IRAS CIT at 17% flat with startup exemption; requires local resident director; IN-SG DTAA provides treaty benefits for Indian parents.
ODI (Overseas Direct Investment) RBI approval required for equity
SG Pte is the ASEAN gold standard for Indian SaaS; IN-SG DTAA + IRAS CIT stability outweighs the nominee director cost.
- 01RBI ODI filing required above USD 250,000 aggregate capital contribution
- 02Nominee director cost SGD 1,800-3,000/year
- 03Singapore CIT 17% flat with startup exemption
- 04Schedule FA disclosure on Indian ITR-2 mandatory; Black Money Act INR 10 lakh penalty
From filing to funded bank account
Singapore Pte Ltd vs UAE Free Zone (MEYDAN)
FAQ
India-Singapore Double Taxation Avoidance Agreement grants: royalties 10% (vs India domestic 20%), dividends 10-15% depending on shareholder stake, fees for technical services 10%. Applies to payments between Indian parent and SG Pte subsidiary. Requires PAN and Tax Residency Certificate (TRC) from IRAS.
Start filing with Osome (Singapore)
Formation typically completes in 2–3 weeks. Use the promo below, then click through to begin the checklist directly on the platform.